Artiva Biotherapeutics (ARTV) EBIT (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported EBIT of -$24.4 million for Q1 2026, down 10.19% year-over-year from -$27.2 million in Q1 2025, and down 11.39% quarter-over-quarter from -$21.9 million in Q4 2025.
Artiva Biotherapeutics (ARTV) EBIT (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of EBIT data on file, last reported at -$24.4 million in Q1 2026.
- EBIT for Q1 2026 came in at -$24.4 million, down 10.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$92.1 million (down 22.82% YoY), and the FY2025 annual result was -$89.8 million, down 33.48% from the prior year.
- EBIT eased to -$24.4 million in Q1 2026 per ARTV's latest filing, from -$21.9 million in the prior quarter.
- Over five years, EBIT peaked at $12.7 million in Q4 2023 and troughed at -$24.4 million in Q1 2026.
- A 4-year average of -$14.2 million and a median of -$18.3 million in 2024 frame the typical range for EBIT.
- The sharpest annual moves came in 2024 and 2026: EBIT slumped 269.6% in 2024, then dropped 10.19% in 2026.
- A 4-year view of EBIT shows it stood at $12.7 million in 2023, then plunged by 244.2% to -$18.3 million in 2024, then decreased by 20.06% to -$21.9 million in 2025, then slipped by 11.39% to -$24.4 million in 2026.
- Business Quant data shows ARTV's EBIT at -$24.4 million in Q1 2026, -$21.9 million in Q4 2025, and -$22.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -24.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.43 Mn |
| Dec 31, 2025 | -21.93 Mn |
| Sep 30, 2025 | -22.90 Mn |
| Jun 30, 2025 | -22.81 Mn |
| Mar 31, 2025 | -22.17 Mn |
| Dec 31, 2024 | -18.27 Mn |
| Sep 30, 2024 | -18.34 Mn |
| Jun 30, 2024 | -16.19 Mn |
| Mar 31, 2024 | -14.49 Mn |
| Dec 31, 2023 | 12.67 Mn |
| Sep 30, 2023 | 10.81 Mn |
| Jun 30, 2023 | -11.82 Mn |